This symposium will provide a comprehensive update on the latest developments in the field of Hematologic Malignancies.  Clinical presentations will cover Myelodysplastic Syndromes, Non-Hodgkin's Lymphoma, CLL and Multiple Myeloma.The goal of this activity is to enhance the care of patients with these diseases and to support quality clinical practice of healthcare professionals involved in their care.

ACCREDITATION AND CREDITS

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

EXCEL Continuing Education designates this educational activity for a maximum of four AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

EXCEL Continuing Education awards 4 contact hours of credit for participation in the activity. FL Board of Nursing provider #50-619

LEARNING OBJECTIVES

Upon completion of this cme activity, the participant should be able to:

- Discuss state of the art research in hematology

- Describe recent advances in the diagnosis and management of major malignant and benign hematologic disorders

- Discuss appropriate uses for newly approved drugs and therapies

-Identify practice behaviors that could be affected by new research

- Employ the knowledge gained to improve patient care

TARGET AUDIENCE

This activity has been designed to meet the educational needs of hematologists, oncologists, nurses, and other healthcare providers interested in acquiring additional knowledge concerning hematologic disorders.

ACKNOWLEDGEMENTS

Supported through grants provided by